Title CYP2C19 and pediatric adverse events during citalopram, escitalopram and sertraline treatment / Katelyn M. Neely [and four others]

Published Itasca, IL : American Academy of Pediatrics, 2020

Click on the following:
Academic Video Online

Copies

Description 1 online resource (5 minutes) Contents CYP2C19 and Pediatric Adverse Events During Citalopram, Escitalopram and Sertraline Treatment (4:17); Summary This retrospective cohort study demonstrates that extrapolation of adult pharmacogenetic guidelines for sertraline, escitalopram, and citalopram and CYP2C19 is not appropriate for pediatric patients Notes Title from resource description page (viewed August 20, 2021) In English Subject Pediatric psychopharmacology. Depression in children -- Treatment Serotonin uptake inhibitors. Depression in children -- Treatment. Pediatric psychopharmacology. Serotonin uptake inhibitors. Genre/Form Educational films. Educational films. Films éducatifs. Form Streaming video Author Neely, Katelyn M., speaker American Academy of Pediatrics, publisher.

  Permalink